Neurocrine Biosciences Inc (NASDAQ:NBIX)

93.25
Delayed Data
As of May 18
 +0.76 / +0.82%
Today’s Change
41.76
Today|||52-Week Range
94.48
+20.18%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close92.49
Today’s open92.52
Day’s range91.68 - 93.72
Volume634,662
Average volume (3 months)854,519
Market cap$8.2B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+0.61%
Earnings growth (this year)+85.99%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+977.51%
P/E ratioNM
Price/Sales42.29
Price/Book21.72

Competitors

----
BLUEbluebird bio Inc-5.60-2.96%
TECHBio-Techne Corp+1.35+0.89%
EXASExact Sciences Corp+1.24+2.43%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$161.6M
Annual profit (last year)-$142.5M
Net profit margin-88.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts